Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Cardiology

Understanding Your Diagnosis of Rheumatic Heart Disease

At a Glance

Rheumatic heart disease is lasting damage to the heart valves after an abnormal immune response to a strep infection. It may be silent, but an echocardiogram can detect it, and regular penicillin injections can help prevent repeat attacks and further damage.

Learning that you or your child has rheumatic heart disease (RHD) can be overwhelming, especially when the cause is a complex immune reaction to a simple sore throat from years ago that may have been forgotten [1]. It is common to feel a mix of shock, guilt, or confusion, but it is important to know that RHD is a global health challenge affecting over 54 million people worldwide [2]. While it is now rare in many high-income countries due to better living conditions and quick access to antibiotics, it remains a serious concern in many other parts of the world [3]. Because it is less common in some regions, your local doctor might not see it often, which can make the diagnosis feel even more isolating [4]. Importantly, developing RHD is not a sign that you or your family failed to treat an illness properly; it is a complex immune reaction in susceptible individuals.

The Link Between a Sore Throat and the Heart

RHD is not a direct bacterial infection of the heart. Instead, it is an autoimmune response—a situation where the body’s immune system accidentally attacks its own healthy tissue [5].

The process begins with a common infection called Group A Streptococcus (GAS), often known as “strep throat” [5]. In some people, the immune system gets confused through a process called molecular mimicry [6]. The proteins on the surface of the GAS bacteria look very similar to certain proteins in the human heart valves [7]. When the immune system creates “soldiers” (antibodies and T cells) to fight the strep throat, those soldiers may mistakenly attack the heart valves instead [8][9].

Acute Rheumatic Fever vs. Rheumatic Heart Disease

It is helpful to think of these as two different stages of the same story:

  • Acute Rheumatic Fever (ARF): This is the immediate, short-term illness that happens about 2 to 4 weeks after a strep infection [5]. It can cause high fevers, painful and swollen joints, or skin rashes [10]. During this stage, the heart valves can become inflamed, a condition called carditis [11].
  • Rheumatic Heart Disease (RHD): This refers to the long-term, permanent damage to the heart valves that remains after the inflammation of ARF has passed [12]. Every time a person has a repeat episode of ARF, the heart damage can get worse [13]. Over time, the valves can become scarred, thickened, or “leaky” (regurgitation) or “tight” (stenosis) [14][15].

The “Silent” Nature of the Disease

One of the most difficult parts of RHD is that it can be latent (silent) for many years [16]. A child may have no symptoms at all while the heart damage is slowly progressing. Often, the disease is only found through an echocardiogram—an ultrasound of the heart—during a routine screening or when a doctor hears a heart murmur [17].

The 2023 World Heart Federation (WHF) guidelines use specific criteria to track the disease on an echocardiogram [17]:

  • Borderline RHD: Mild or early findings that are suspicious but do not yet meet the full criteria for definite disease; these might improve or stay stable with proper care [18][19].
  • Definite RHD: Clear evidence of rheumatic valve damage, ranging from mild to severe, which may eventually require surgery if it advances [20].

Protecting the Heart for the Future

The most important thing to know is that RHD progression can often be stopped. The primary tool for this is secondary antibiotic prophylaxis [21]. This usually involves an injection of penicillin (benzathine benzylpenicillin G) every four weeks [22].

These injections do not directly “erase” established valve scarring, but they prevent new strep infections from triggering another round of the autoimmune attack [23]. In a recent trial of children with early RHD in an endemic region, those who received regular penicillin injections were significantly less likely to see their heart disease progress on an echocardiogram compared to those who did not (0.8% vs. 8.2%) [22].

Coping with the Diagnosis

It is normal to feel anxious or depressed after receiving this diagnosis [1]. Families often face practical challenges, such as the pain of regular injections, the cost of travel to clinics, or the stress of missing school or work [24][25].

Connecting with peer-support groups—other families going through the same thing—has been shown to improve quality of life and help patients stay on track with their treatment [26]. While the road ahead requires regular medical care, many people with RHD live full, active lives when the disease is managed early and consistently [27].

Common questions in this guide

How can a sore throat lead to rheumatic heart disease?
Group A Streptococcus, the bacteria that causes strep throat, can trigger an abnormal immune response in some people. The immune system may mistakenly attack the heart valves, causing inflammation and lasting scar tissue. Rheumatic heart disease is not a direct infection of the heart.
Is acute rheumatic fever the same as rheumatic heart disease?
No. Acute rheumatic fever is a short-term illness that can develop two to four weeks after a strep infection and may inflame the heart. Rheumatic heart disease is the lasting valve damage that can remain after that inflammation, and repeat episodes can worsen it.
How is rheumatic heart disease found if I do not have symptoms?
Rheumatic heart disease can remain silent for years. An echocardiogram, which is an ultrasound of the heart, can reveal valve changes during screening or after a clinician hears a heart murmur. Doctors use the findings to classify disease as borderline or definite.
What do borderline and definite rheumatic heart disease mean?
Borderline disease means the echocardiogram shows mild or early changes that are suspicious but do not meet the full criteria for definite disease. Definite disease means there is clear evidence of rheumatic valve damage, ranging from mild to severe. This classification helps guide monitoring and care.
Can penicillin injections stop rheumatic heart disease from getting worse?
Regular secondary antibiotic prophylaxis, often a benzathine penicillin injection every four weeks, helps prevent new strep infections from triggering another immune attack. It does not remove valve scarring that is already present, but it can reduce the risk of further damage. The care team determines how long treatment should continue.
What does it mean if a heart valve is leaky or tight?
A leaky valve has regurgitation, meaning blood can flow backward through the valve. A tight valve has stenosis, meaning the opening is narrowed and blood has more difficulty passing through. Echocardiograms help show which valves are affected and how severe the changes are.
Can people with rheumatic heart disease live active lives?
Many people with rheumatic heart disease live full, active lives when the condition is identified early and managed consistently. Ongoing medical visits, recommended antibiotic prophylaxis, and repeat echocardiograms help the care team monitor the valves. Emotional and practical support can also make long-term care easier.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my echocardiogram, do I have 'Definite' or 'Borderline' RHD according to the World Heart Federation criteria?
  2. 2.What is the specific plan for my secondary antibiotic prophylaxis, and how many years will I likely need these injections?
  3. 3.Are there signs of active inflammation right now, or is this chronic damage from a past infection?
  4. 4.How often do we need to repeat the echocardiogram to monitor for changes in my heart valves?
  5. 5.Can you explain the results of my valve assessment—which valves are affected, and is it 'leaking' (regurgitation) or 'tight' (stenosis)?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (27)
  1. 1

    The Impact of Echocardiographic Screening for Rheumatic Heart Disease on Patient Quality of Life.

    Bradley-Hewitt T, Dantin A, Ploutz M, et al.

    The Journal of pediatrics 2016; (175()):123-9.

    PMID: 27268786
  2. 2

    Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021.

    Chen QF, Shi S, Wang YF, et al.

    Journal of the American Heart Association 2024; (13(24)):e037991 doi:10.1161/JAHA.124.037991.

    PMID: 39673328
  3. 3

    Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015.

    Watkins DA, Johnson CO, Colquhoun SM, et al.

    The New England journal of medicine 2017; (377(8)):713-722 doi:10.1056/NEJMoa1603693.

    PMID: 28834488
  4. 4

    Rheumatic Heart Disease: The Unfinished Global Agenda.

    Nulu S, Bukhman G, Kwan GF

    Cardiology clinics 2017; (35(1)):165-180 doi:10.1016/j.ccl.2016.08.006.

    PMID: 27886787
  5. 5

    Myocarditis Following Invasive Group A Streptococcus Infection: Important Differential Diagnostic Distinctions.

    Oxman JM, Bourne M, Perlman DC, Sells N

    Case reports in infectious diseases 2026; (2026()):5349221 doi:10.1155/crdi/5349221.

    PMID: 41953693
  6. 6

    Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

    Cunningham MW

    Microbiology spectrum 2019; (7(4)) doi:10.1128/microbiolspec.GPP3-0045-2018.

    PMID: 31373269
  7. 7

    Genome-Wide Analysis of Genetic Risk Factors for Rheumatic Heart Disease in Aboriginal Australians Provides Support for Pathogenic Molecular Mimicry.

    Gray LA, D'Antoine HA, Tong SYC, et al.

    The Journal of infectious diseases 2017; (216(11)):1460-1470 doi:10.1093/infdis/jix497.

    PMID: 29029143
  8. 8

    Dysregulated IL-1β-GM-CSF Axis in Acute Rheumatic Fever That Is Limited by Hydroxychloroquine.

    Kim ML, Martin WJ, Minigo G, et al.

    Circulation 2018; (138(23)):2648-2661 doi:10.1161/CIRCULATIONAHA.118.033891.

    PMID: 30571257
  9. 9

    Rapid screening for acute rheumatic fever using machine learning analysis of host tissue reactive antibodies.

    Vo B, Rafeek RAM, Surve NZ, et al.

    Scientific reports 2025; (15(1)):41316 doi:10.1038/s41598-025-25171-5.

    PMID: 41271880
  10. 10

    Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association.

    Gewitz MH, Baltimore RS, Tani LY, et al.

    Circulation 2015; (131(20)):1806-18 doi:10.1161/CIR.0000000000000205.

    PMID: 25908771
  11. 11

    Sydenham's chorea in a 16-year-old female from Bhutan: A case report.

    Penjor T, Dorji T, Wangchuk S

    Clinical case reports 2024; (12(7)):e9047 doi:10.1002/ccr3.9047.

    PMID: 38911918
  12. 12

    Valve biology and rheumatic heart disease pathogenesis.

    Yeow S, Frost H, Porrello ER, et al.

    Nature cardiovascular research 2026; (5(3)):204-217 doi:10.1038/s44161-026-00792-9.

    PMID: 41807679
  13. 13

    Acute rheumatic fever and rheumatic heart disease.

    Carapetis JR, Beaton A, Cunningham MW, et al.

    Nature reviews. Disease primers 2016; (2()):15084 doi:10.1038/nrdp.2015.84.

    PMID: 27188830
  14. 14

    Echocardiography Screening for Latent Rheumatic Heart Disease: What Can We Do in Indonesia?

    Soesanto AM, Suastika LOS

    Frontiers in surgery 2020; (7()):46 doi:10.3389/fsurg.2020.00046.

    PMID: 32974379
  15. 15

    Inhibition of Endothelial-Mesenchymal Transition Mediated by Activin Receptor Type IIA Attenuates Valvular Injury Induced by Group A Streptococcus in Lewis Rats.

    Lu Z, Li Y, Lu C, et al.

    Frontiers in bioscience (Landmark edition) 2025; (30(1)):26370 doi:10.31083/FBL26370.

    PMID: 39862082
  16. 16

    Early rheumatic heart disease is a recognized intermediate on the pathway to advanced rheumatic heart disease.

    Marangou J, Wirth SH, Zühlke L, et al.

    International journal of cardiology 2026; (453()):134432 doi:10.1016/j.ijcard.2026.134432.

    PMID: 41833866
  17. 17

    2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease.

    Rwebembera J, Marangou J, Mwita JC, et al.

    Nature reviews. Cardiology 2024; (21(4)):250-263 doi:10.1038/s41569-023-00940-9.

    PMID: 37914787
  18. 18

    Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).

    Rwebembera J, Ndagire E, Carvalho N, et al.

    American heart journal 2024; (275()):74-85 doi:10.1016/j.ahj.2024.05.012.

    PMID: 38797460
  19. 19

    Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.

    Beaton A, Aliku T, Dewyer A, et al.

    Circulation 2017; (136(23)):2233-2244 doi:10.1161/CIRCULATIONAHA.117.029936.

    PMID: 28972003
  20. 20

    The Impact of Acute Rheumatic Fever Diagnosis on Rheumatic Heart Disease Severity.

    Williamson JM, Whalley G, Thornley S, et al.

    Global heart 2025; (20(1)):72 doi:10.5334/gh.1454.

    PMID: 40894083
  21. 21

    Therapeutics for rheumatic fever and rheumatic heart disease.

    Ralph AP, Currie BJ

    Australian prescriber 2022; (45(4)):104-112 doi:10.18773/austprescr.2022.034.

    PMID: 36110174
  22. 22

    Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.

    Beaton A, Okello E, Rwebembera J, et al.

    The New England journal of medicine 2022; (386(3)):230-240 doi:10.1056/NEJMoa2102074.

    PMID: 34767321
  23. 23

    Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease.

    Bray JJ, Thompson S, Seitler S, et al.

    The Cochrane database of systematic reviews 2024; (9()):CD015779 doi:10.1002/14651858.CD015779.

    PMID: 39312290
  24. 24

    Patient preferences for prophylactic regimens requiring regular injections in children and adolescents: a systematic review and thematic analysis.

    Ilievski J, Mirams O, Trowman R, et al.

    BMJ paediatrics open 2024; (8(1)) doi:10.1136/bmjpo-2023-002450.

    PMID: 38769047
  25. 25

    The economic burden of rheumatic heart disease in the Eastern Mediterranean Region.

    Elmusharaf K, Poix S, Scaria EB, et al.

    BMJ global health 2025; (10(10)) doi:10.1136/bmjgh-2024-018277.

    PMID: 41062128
  26. 26

    The impact of a peer support group for children with rheumatic heart disease in Uganda.

    Scheel A, Beaton A, Okello E, et al.

    Patient education and counseling 2018; (101(1)):119-123 doi:10.1016/j.pec.2017.07.006.

    PMID: 28716486
  27. 27

    Health Related Quality of Life of Ugandan Children Following Valve Replacement Surgery for Rheumatic Heart Disease.

    Ahmed MAM, Aliku T, Namuyonga J, et al.

    Global heart 2023; (18(1)):37 doi:10.5334/gh.1205.

    PMID: 37361321

This page explains rheumatic heart disease diagnoses, echocardiogram findings, and prevention of further valve damage for informational purposes only and does not constitute medical advice. Your cardiology team should interpret your results and tailor antibiotic treatment to your needs.

Get notified when new evidence is published on rheumatic heart disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.